HEALTH PROFESSIONAL · SOURCE READING

Chemotherapy

Source: Childhood Rhabdomyosarcoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.

Source updated: April 11, 2025 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.

Context: Treatment of Childhood Rhabdomyosarcoma

All children with rhabdomyosarcoma should receive chemotherapy. The intensity and duration of the chemotherapy are dependent on the Risk Group assignment.[171] For more information about Risk Groups, see Table 6.

Source links and citations

Adolescents treated with chemotherapy for rhabdomyosarcoma experience less hematologic toxicity and more peripheral nerve toxicity than do younger patients.[172]

Source links and citations

Continue within this section

Low-risk Group →Intermediate-risk Group →High-risk Group →

Publication references

Read the original reference and check its publication notices.

Preserved source evidence · Not medical advice